Related Experiment Video
Updated: Apr 19, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics
Yasuyuki Kinjo1, Kazuaki Yoshimura, Takashi Suzuki
1Department of Internal Medicine, Nanbu Tokushukai Hospital.
Abstract:
Acquired factor V (FV) inhibitor is a rare coagulation disorder, the causes and clinical symptoms of which are known to vary widely. Acquired FV inhibitor mostly occurs with exposure to fibrin glues during surgical procedures. We experienced a case with asymptomatic acquired FV inhibitor caused by antibiotic therapy for aspiration pneumonia.A man in his eighties had been treated for chronic atrial fibrillation, cerebral infarction and spinal canal stenosis. He was admitted after antibiotic therapy for aspiration pneumonia in a previous hospital. On admission, the screening test for blood coagulation revealed extreme prolongation of both prothrombin time (PT) and activated partial thromboplastin time (APTT). Vitamin K was administered intravenously after cessation of warfarin, but neither PT nor APTT showed any improvement. Subsequently, a cross mixing test was performed and showed an inhibitor pattern. Furthermore, a high titer of FV inhibitor was detected by the Bethesda method and an acquired FV inhibitor was thus diagnosed. Despite the presence of FV inhibitor, the patient showed no bleeding symptoms. Eight months later, both PT and APTT had diminished to normal clotting time values without immunosuppressive therapies.
Insights
An acquired factor V inhibitor, a rare bleeding disorder, can develop unexpectedly. This case highlights antibiotic therapy as a potential cause, even without bleeding symptoms.
Area of Science:
- Hematology
- Coagulation Disorders
- Internal Medicine
Background:
- Acquired factor V (FV) inhibitor is a rare coagulation disorder with diverse causes and symptoms.
- It is most commonly associated with exposure to fibrin glues during surgical procedures.
- This report details an unusual case linked to antibiotic therapy.
Observation:
- An elderly male patient presented with extremely prolonged prothrombin time (PT) and activated partial thromboplastin time (APTT) after antibiotic treatment for aspiration pneumonia.
- Standard interventions, including vitamin K and warfarin cessation, did not resolve the coagulation abnormalities.
- Diagnostic tests confirmed the presence of a high-titer factor V inhibitor.
Findings:
- The patient was diagnosed with an asymptomatic acquired factor V inhibitor.
- Despite the inhibitor, no bleeding symptoms were observed.
- Coagulation parameters normalized spontaneously within eight months without immunosuppressive treatment.
Implications:
- Antibiotic therapy should be considered as a potential trigger for acquired FV inhibitors.
- The case underscores the possibility of asymptomatic FV inhibitors.
- Spontaneous resolution of acquired FV inhibitors is possible, even in the absence of immunosuppression.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Clinical Significance of Antibiotic Resistance
Endocarditis III: Medical Management

